Esperion Therapeutics, Inc.
In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies.